D
3D Systems Corporation DDD
$1.96 $0.010.51% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

3D Systems Corporation is a U.S.-based additive manufacturing company that designs, develops, and sells 3D printing hardware, materials, software, and on-demand manufacturing services. The company operates primarily within the additive manufacturing, advanced manufacturing, and healthcare technology industries. Its offerings support the full additive manufacturing workflow, from digital design and print preparation software to industrial-scale printers and certified materials.

The company’s primary revenue drivers are its Industrial and Healthcare business lines, which serve customers in aerospace, defense, automotive, semiconductor, dental, medical device, and bioprinting research markets. 3D Systems is widely recognized for its foundational role in the industry, having commercialized stereolithography (SLA)—one of the earliest and most widely adopted 3D printing technologies. Founded in 1986 by Chuck Hull, the company has evolved from a prototyping-focused firm into a diversified additive manufacturing platform serving both production and clinical applications.

Business Operations

3D Systems organizes its operations into two primary reporting segments: Industrial and Healthcare. The Industrial segment generates revenue through the sale of professional and production-grade 3D printers, print materials, software solutions, and maintenance services used for rapid prototyping and end-use part manufacturing. Key technologies include stereolithography (SLA), selective laser sintering (SLS), direct metal printing (DMP), and Figure 4® production platforms.

The Healthcare segment focuses on dental, medical device, and regenerative medicine applications, providing specialized printers, biocompatible materials, digital dentistry solutions, and patient-specific surgical planning tools. The company also operates on-demand manufacturing services and maintains proprietary software platforms that integrate design, simulation, and production workflows. Operations span both domestic and international markets, supported by wholly owned subsidiaries and regional sales, service, and manufacturing facilities.

Strategic Position & Investments

3D Systems’ strategy emphasizes higher-margin, application-specific solutions, with a focus on regulated healthcare markets and industrial production environments where additive manufacturing provides measurable performance advantages. Growth initiatives include expanding production-scale additive manufacturing, increasing recurring materials and software revenue, and advancing personalized healthcare solutions.

The company has made targeted acquisitions to strengthen its software and healthcare capabilities, including Oqton, an industrial manufacturing software platform, and Volumetric Biotechnologies, a regenerative medicine and bioprinting company. Through these investments, 3D Systems has increased its exposure to bioprinting, digital manufacturing automation, and AI-enabled production workflows. These areas are positioned as long-term growth vectors aligned with advanced manufacturing and next-generation medical applications.

Geographic Footprint

3D Systems is headquartered in Rock Hill, South Carolina, and operates across North America, Europe, and Asia-Pacific. The company maintains manufacturing, R&D, and customer support facilities in the United States, Germany, the United Kingdom, France, Italy, the Netherlands, Japan, and China, among other locations.

Its global footprint supports a diversified customer base, including multinational industrial manufacturers, dental laboratories, hospitals, and research institutions. International operations account for a significant portion of total revenue, with Europe historically representing one of the company’s largest non-U.S. markets, alongside growing activity in Asia-Pacific.

Leadership & Governance

3D Systems was founded by Chuck Hull, the inventor of stereolithography, who continues to play a key role in the company’s technology strategy. The leadership team is responsible for executing a long-term vision centered on industrial-scale additive manufacturing and healthcare innovation, with an emphasis on disciplined capital allocation and profitability.

Key executives, based on the most recent publicly available company disclosures, include:

  • Jeffrey A. Graves – President & Chief Executive Officer
  • Andrew Johnson – Executive Vice President & Chief Financial Officer
  • Chuck Hull – Co-Founder & Chief Technology Officer
  • Eric Tobler – Executive Vice President & Chief Operating Officer
  • Scott Turner – Executive Vice President, Healthcare Solutions

The company is governed by a board of directors with experience across manufacturing, healthcare, and public company leadership, and management has articulated a strategy focused on operational efficiency, targeted investment, and sustainable long-term growth.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $167.80
B
AAPL NASDAQ $247.35
B
AVGO NASDAQ $300.45
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $123.88
B
Top Financial Stocks
See All »
B
B
JPM NYSE $286.15
B
V NYSE $299.74
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $894.50
B
JNJ NYSE $241.81
B
AMGN NASDAQ $350.54
Top Real Estate Stocks
See All »
B
PLD NYSE $130.10